Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: Lessons learned from the pandemic

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue SUPPL. 4, 2012, Pages 49-53

  López Medrano, Francisco ^a   Carmen Fariñas, María ^b   Payeras, Antonio ^c   Pachón, Jerónimo ^d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

A(H1N1)pdm09 influenza virus; Neuraminidase inhibitors; Oseltamivir; Vaccine

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; PERAMIVIR; PLACEBO; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; FEVER; HOSPITAL ADMISSION; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LENGTH OF STAY; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRUS STRAIN;

ANTIVIRAL AGENTS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEURAMINIDASE; PANDEMICS;

EID: 84868149478     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(12)70105-2     Document Type: Article

References (52)

1. R. Pérez-Padilla, D. De la Rosa-Zamboni, S. Ponce de Leon, M. Hernandez, F. Quiñones-Falconi, E. Bautista INER Working Group on Influenza Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico N Engl J Med 361 2009 680 689
2. E. Bautista, T. Chotpitayasunondh, Z. Gao, S.A. Harper, M. Shaw, and T.M. Uyeki Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection N Engl J Med 362 2010 1708 1719
3. Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain New influenza A(H1N1) virus infections in Spain, April-May 2009 Euro Surveill 14 2009 19209
4. Centers for Disease and Control and Prevention (CDC) Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009 MMWR Morb Mortal Wkly Rep 58 2009 433 435
5. A. Moscona Neuraminidase inhibitors for influenza N Engl J Med 353 2005 1363 1373 (Pubitemid 41362704)
6. T. Jefferson, M. Jones, P. Doshi, and C. Del Mar Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis BMJ 339 2009 b5106
7. T. Jefferson, M.A. Jones, P. Doshi, C.B. Del Mar, C.J. Heneghan, and R. Hama Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children Cochrane Database Syst Rev 1 2012 CD008965
8. J. Hsu, N. Santesso, R. Mustafa, J. Brozek, Y.L. Chen, and J.P. Hopkins Antivirals for treatment of influenza: A systematic review and meta-analysis of observational studies Ann Intern Med 156 2012 512 524
9. D. Viasus, J.R. Paño-Pardo, J. Pachón, A. Campins, F. López-Medrano, A. Villoslada Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI) Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain Clin Microbiol Infect 17 2011 738 746
10. D. Viasus, J.R. Paño-Pardo, J. Pachón, M. Riera, F. López-Medrano, and A. Payeras Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection Chest 140 2011 1025 1032
11. D. Viasus, J.R. Paño-Pardo, J. Pachón, M. Riera, F. López-Medrano, A. Payeras Novel Influenza A(H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI) Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes Medicine (Baltimore) 90 2011 328 336
12. A. Kumar Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life J Antimicrob Chemother 66 2011 959 963
13. Y.S. Chien, C.P. Su, H.T. Tsai, A.S. Huang, C.E. Lien, and M.N. Hung Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan J Infect 60 2010 168 174
14. H. Yu, Q. Liao, Y. Yuan, L. Zhou, N. Xiang, and Y. Huai Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China BMJ 341 2010 c4779
15. L.M. Ling, A.L. Chow, D.C. Lye, A.S. Tan, P. Krishnan, and L. Cui Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection Clin Infect Dis 50 2010 963 969
16. J.R. Smith, C.R. Rayner, B. Donner, M. Wollenhaupt, K. Klumpp, and R. Dutkowski Oseltamivir in seasonal, pandemic, and avian influenza: A comprehensive review of 10-years clinical experience Adv Ther 28 2011 927 959
17. G. Domínguez-Cherit, S.E. Lapinsky, A.E. Macias, R. Pinto, L. Espinosa-Perez, and A. De la Torre Critically ill patients with 2009 influenza A(H1N1) in Mexico JAMA 302 2009 1880 1887
18. S.E. Coffin, K. Leckerman, R. Keren, M. Hall, R. Localio, and T.E. Zaoutis Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: A retrospective cohort study Pediatr Infect Dis J 30 2011 962 966
19. J.K. Louie, M. Acosta, D.J. Jamieson, and M.A. Honein Severe 2009 H1N1 influenza in pregnant and postpartum women in California N Engl J Med 362 2010 27 35
20. L.G. Mosby, S.A. Rasmussen, and D.J. Jamieson 2009 pandemic influenza A (H1N1) in pregnancy: A systematic review of the literature Am J Obstet Gynecol 205 2011 10 18
21. A.M. Siston, S.A. Rasmussen, M.A. Honein, A.M. Fry, K. Seib, and W.M. Callaghan Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States JAMA 303 2010 1517 1525
22. D. Kumar, M.G. Michaels, M.I. Morris, M. Green, R.K. Avery, and C. Liu Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: A multicentre cohort study Lancet Infect Dis 10 2010 521 526
23. C.L. Cooper Pandemic H1N12009 influenza and HIV: A review of natural history, management and vaccine immunogenicity Curr Opin Infect Dis 25 2012 26 35
24. M. Riera, A. Payeras, M.A. Marcos, D. Viasus, M.C. Fariñas, and F. Segura Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: A Spanish multicenter study AIDS 24 2010 2461 2467
25. A.C. Hurt, T. Chotpitayasunondh, N.J. Cox, R. Daniels, A.M. Fry, and L.V. Gubareva Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives Lancet Infect Dis 12 2012 240 248
26. J. Ledesma, D. Vicente, F. Pozo, G. Cilla, S.P. Castro, J.S. Fernández Spanish Influenza Surveillance System (SISS) Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain J Clin Virol 51 2011 205 208
27. A.H. Gaur, B. Bagga, S. Barman, R. Hayden, A. Lamptey, and J.M. Hoffman Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza N Engl J Med 362 2010 88 89
28. A. Sorbello, S.C. Jones, W. Carter, K. Struble, R. Boucher, and M. Truffa Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus Clin Infect Dis 55 2012 1 7
29. D. Viasus, J.R. Paño-Pardo, E. Cordero, A. Campins, F. López-Medrano, and A. Villoslada Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia J Infect 62 2011 193 199
30. M.E. Falagas, E.K. Vouloumanou, E. Baskouta, P.I. Rafailidis, K. Polyzos, and J. Rello Treatment options for 2009 H1N1 influenza: evaluation of the published evidence Int J Antimicrob Agents 35 2010 421 430
31. I. Martin-Loeches, T. Lisboa, A. Rhodes, R.P. Moreno, E. Silva, and C. Sprung Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection Intensive Care Med 37 2010 272 283
32. X. Xi, Y. Xu, L. Jiang, A. Li, J. Duan, and B. Du Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality BMC Infect Dis 10 2010 256
33. A. Davies, D. Jones, M. Bailey, J. Beca, R. Bellomo, and N. Blackwell Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome JAMA 302 2009 1888 1895
34. M.D. Mitchell, M.E. Mikkelsen, C.A. Umscheid, I. Lee, B.D. Fuchs, and S.D. Halpern A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic Crit Care Med 38 2010 1398 1404
35. A. Combes, M. Bacchetta, D. Brodie, T. Muller, and V. Pellegrino Extracorporeal membrane oxygenation for respiratory failure in adults Curr Opin Crit Care 18 2012 99 104
36. D. Viasus, E. Cordero, J. Rodríguez-Baño, J.A. Oteo, A. Fernández-Navarro, and L. Ortega Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI). Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season Clin Microbiol Infect 18 2012 E55 E62
37. World Health Organization Influenza A(H1N1) 2009 virus: current situation and post-pandemic recommendations Wkly Epidemiol Rec 86 2011 61 65
38. M.K. Goel, M. Goel, P. Khanna, and K. Mittal Pandemic influenza A (H1N1) 2009 vaccine: an update Indian J Med Microbiol 29 2011 13 18
39. E. Plennevaux, E. Sheldon, M. Blatter, M.K. Reeves-Hoche, and M. Denis Immune response after a single vaccination against 2009 influenza A H1N1 in USA: A preliminary report of two randomised controlled phase 2 trials Lancet 375 2010 41 48
40. Z. Vajo, F. Tamas, L. Sinka, and I. Jankovics Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: A multicentre, randomised controlled trial Lancet 375 2010 49 55
41. X.F. Liang, H.Q. Wang, J.Z. Wang, H.H. Fang, J. Wu, and F.C. Zhu Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, doubleblind, randomised, placebo-controlled trial Lancet 375 2010 56 66
42. J.K. Yin, G. Khandaker, H. Rashid, L. Heron, I. Ridda, and R. Booy Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis Influenza Other Respi Viruses 5 2011 299 305
43. M.E. Wise, M. Viray, J.J. Sejvar, P. Lewis, A.L. Baughman, and W. Connor Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans Am J Epidemiol 175 2012 1110 1119
44. E. Cordero, A. Perez-Ordoñez, T.A. Aydillo, J. Torre-Cisneros, J. Gavalda, and R. Lara Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients Am J Transplant 11 2011 2205 2213
45. C. Rodríguez-Rieiro, M.D. Esteban-Vasallo, M.F. Domínguez-Berjón, J. Astray-Mochales, D. Iniesta-Fornies, and D. Barranco-Ordoñez Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain Vaccine 29 2011 1332 1338
46. S. Virseda, M.A. Restrepo, E. Arranz, P. Magán-Tapia, M. Fernández-Ruiz, and A.G. De la Camara Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital Vaccine 28 2010 4751 4757
47. S. Brien, J.C. Kwong, and D.L. Buckeridge The determinants of 2009 pandemic A/H1N1 influenza vaccination: A systematic review Vaccine 30 2012 1255 1264
48. A. Bish, L. Yardley, A. Nicoll, and S. Michie Factors associated with uptake of vaccination against pandemic influenza: A systematic review Vaccine 29 2011 6472 6484
49. D. Ofri The emotional epidemiology of H1N1 influenza vaccination N Engl J Med 361 2009 2594 2595
50. G.A. Poland The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns Vaccine 28 Suppl 4 2010 D3 D13
51. M. Friede, L. Palkonyay, C. Alfonso, Y. Pervikov, G. Torelli, and D. Wood WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer Vaccine 29 Suppl 1 2011 A2 A7
52. P. LaRussa Pandemic novel 2009 H1N1 influenza: what have we learned? Semin Respir Crit Care Med 32 2011 393 399